Literature DB >> 10969312

Comparative ventricular electrophysiologic effect of racemic bupivacaine, levobupivacaine, and ropivacaine on the isolated rabbit heart.

J X Mazoit1, A Decaux, H Bouaziz, A Edouard.   

Abstract

BACKGROUND: Numerous local anesthetics have an asymmetric tetrahedron carbon, which confers stereoselective differences between the isomers. The authors attempted to quantify the depressant effect of racemic bupivacaine, levobupivacaine, and ropivacaine on myocardial ventricular conduction and on myocardial contractility.
METHODS: The authors studied the pharmacokinetics (outflow concentration) and pharmacodynamics (QRS widening) of the three drugs infused in an isolated rabbit heart preparation. All data were fitted simultaneously with use of mixed-effect modeling, thus allowing precise statistical comparison between the three drug parameters. The rate dependence of QRS widening was fitted separately.
RESULTS: Racemic bupivacaine, levobupivacaine, and ropivacaine induced a calculated maximum increase in QRS duration in the ratio 1:0.4:0.3. Css50, the dose which caused half the maximum increase in QRS duration at steady state, was similar for all three drugs (22 micrometer free concentration). A rate dependence of QRS widening was observed, which was in the ratio 1:0.5:0.25 for racemic bupivacaine, levobupivacaine, and ropivacaine, respectively.
CONCLUSIONS: In the isolated rabbit heart, racemic bupivacaine, levobupivacaine, and ropivacaine induce an increase in QRS duration in the respective ratio of 1:0.4:0.3, which was rate dependent in approximately the same ratio.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10969312     DOI: 10.1097/00000542-200009000-00028

Source DB:  PubMed          Journal:  Anesthesiology        ISSN: 0003-3022            Impact factor:   7.892


  10 in total

Review 1.  [Levobupivacaine for regional anesthesia. A systematic review].

Authors:  B Urbanek; S Kapral
Journal:  Anaesthesist       Date:  2006-03       Impact factor: 1.041

2.  Direct cardiac effects of intracoronary bupivacaine, levobupivacaine and ropivacaine in the sheep.

Authors:  D H Chang; L A Ladd; S Copeland; M A Iglesias; J L Plummer; L E Mather
Journal:  Br J Pharmacol       Date:  2001-02       Impact factor: 8.739

3.  Cardiac and CNS toxicity of levobupivacaine: strengths of evidence for advantage over bupivacaine.

Authors:  Robert W Gristwood
Journal:  Drug Saf       Date:  2002       Impact factor: 5.606

4.  A Randomized Controlled Study of 0.5% Bupivacaine, 0.5% Ropivacaine and 0.75% Ropivacaine for Supraclavicular Brachial Plexus Block.

Authors:  Ranjan R Venkatesh; Prabhat Kumar; Ramachandran R Trissur; Sagiev Koshy George
Journal:  J Clin Diagn Res       Date:  2016-12-01

5.  The effects of ropivacaine at clinically relevant doses on myocardial ischemia in pigs.

Authors:  Panayota Tsibiribi; Cécile Bui-Xuan; Bernard Bui-Xuan; Alain Tabib; Jacques Descotes; Philippe Chevalier; Marie-Claude Gagnieu; Majda Belkhiria; Quadiri Timour
Journal:  J Anesth       Date:  2006       Impact factor: 2.078

Review 6.  Pharmacokinetics of local anaesthetics in infants and children.

Authors:  Jean-Xavier Mazoit; Bernard J Dalens
Journal:  Clin Pharmacokinet       Date:  2004       Impact factor: 6.447

7.  Effects on QTc Interval of 2 Different Doses of Spinal Anesthesia in Inguinal Hernia Operations.

Authors:  Onur Hanbeyoglu; Aykut Urfalioglu; Fatih Mehmet Yazar; Sibel Ozcan
Journal:  Med Sci Monit       Date:  2017-03-12

8.  Efficacy of Adding Dexmedetomidine to Intra-articular Levobupivacaine on Postoperative Pain after Knee Arthroscopy.

Authors:  Mohamed Maher El Baz; Tamer El Metwally Farahat
Journal:  Anesth Essays Res       Date:  2019 Apr-Jun

9.  Update on local anesthetics: focus on levobupivacaine.

Authors:  Crina L Burlacu; Donal J Buggy
Journal:  Ther Clin Risk Manag       Date:  2008-04       Impact factor: 2.423

Review 10.  Chiral Aspects of Local Anesthetics.

Authors:  Ružena Čižmáriková; Jozef Čižmárik; Jindra Valentová; Ladislav Habala; Mário Markuliak
Journal:  Molecules       Date:  2020-06-12       Impact factor: 4.411

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.